Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-18-000003

CEO acquired 81,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-08-03 Grant or award : show line 1 in the form +81,250 $1.24 $100,750 7,593,804 D
Loading xslF345X03/primary_doc.xml…